46P Prognostic impact of immune checkpoint inhibition in patients with metastatic non-small cell lung cancer (NSCLC): Real-world study in central Switzerland
| Autor: | Allmann, V., Gautschi, O., Lehnick, D., Dyntar, D., Schwegler, C., Dressler, M., Godau, J., Niederberger, P., Zeidler, K., Diebold, J. |
|---|---|
| Zdroj: | In Annals of Oncology April 2022 33 Supplement 2:S53-S53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|